Trials evaluating treatment interruptions in adults have reported higher rates of AIDS events/death and serious non-AIDS events in those stopping ART [8–12], and the SMART trial reported that CD4-guided episodic use of ART resulted in inferior quality of life (QOL) [13]. Here, CD4 is linked to AIDS.